Skip to main content
Fuan Pharmaceutical （Group）co.,Ltd logo

Fuan Pharmaceutical （Group）co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,013 across all filing types
Latest filing 2021-11-22 Investor Presentation
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical （Group）co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
关于参加重庆辖区上市公司2021年投资者网上集体接待日活动的公告
Investor Presentation Classification · 85% confidence The document is a short announcement about the company's participation in an investor online collective reception day event. It mentions the date and time of the event and the participation of key company officers for communication with investors. There is no financial data, no detailed report, no voting results, no regulatory filing, or other specific report content. The document is an announcement related to investor relations activities, not a report or transcript. Given the nature of the event and the content, this fits best under Investor Presentation (IP) as it is a detailed presentation for investors focusing on company governance, strategy, and operations through an online event.
2021-11-22 Chinese
关于子公司收到盐酸氨溴索注射液药品补充申请批准通知书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (833 characters) about a subsidiary receiving approval from the National Medical Products Administration for a drug supplement application. It contains no financial data, no detailed report, and no mention of financial results or management changes. It is an official announcement regarding regulatory approval related to the company's product line. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a report publication announcement since it does not mention any report being published or attached. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2021-11-22 Chinese
独立董事候选人声明（陈耿）
Board/Management Information Classification · 95% confidence The document is a detailed declaration by an independent director candidate of a company, confirming compliance with various legal and regulatory requirements for serving as an independent director. It includes statements about qualifications, independence, and adherence to relevant laws and regulations. There is no financial data, no mention of financial results, no report or presentation content, and no announcement of voting results or management changes. The document is a formal declaration related to board/management information, specifically about an independent director candidate's qualifications and independence. Therefore, it fits best under the category of Board/Management Information (MANG). The document length (5214 characters) and content confirm it is not a brief announcement or a report publication announcement but a substantive declaration related to management.
2021-11-19 Chinese
董事会议事规则（2021年11月）
Governance Information Classification · 95% confidence The document is titled '董事会议事规则' which translates to 'Rules of Procedure for the Board of Directors Meeting' of 福安药业（集团）股份有限公司. The content details the governance structure, duties, meeting procedures, voting rules, and responsibilities of the board and its secretary. It references company law, regulatory guidelines, and internal company bylaws. There is no financial data, earnings information, or report publication mentioned. The document is a governance-related internal rules document rather than a report or announcement. Therefore, it fits the category of Governance Information (CGR). The document length and detail support this classification with high confidence.
2021-11-19 Chinese
关于监事会换届选举的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election of the supervisory board members (监事会换届选举) of the company 福安药业（集团）股份有限公司. It details the nomination of candidates for the supervisory board, the process of election at the shareholders' meeting, and the qualifications and backgrounds of the candidates. There is no financial data, no mention of financial results, nor is it a report or presentation. It is clearly an announcement about changes in the company's supervisory board, which falls under the category of Board/Management Information (MANG). The document length is short (1399 characters), and it is not a report publication announcement or regulatory filing. Therefore, the appropriate classification is MANG with high confidence.
2021-11-19 Chinese
关于董事会换届选举的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election of a new board of directors for the company 福安药业（集团）股份有限公司. It details the nomination and qualifications of candidates for the fifth board, the process of election, and the term of office. There is no financial data, earnings information, or report publication mentioned. The content focuses exclusively on changes and nominations related to the company's board of directors. Therefore, this fits the category of Board/Management Information (MANG). The document length is 3718 characters, which is consistent with an announcement rather than a full report.
2021-11-19 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.